Item 5.07 Submission of Matters to a Vote of Security Holders.



At Cyclerion Therapeutics, Inc.'s (the "Company") annual meeting of stockholders
held on June 14, 2022, as contemplated by the Company's definitive proxy
material for the meeting, certain matters were submitted to a vote of
stockholders. The following tables summarizes the results of voting with respect
to each matter:

1. Election of Directors:


                              For       Withheld   Broker Non-Votes
George Conrades            22,855,013   184,521       7,253,724
Errol De Souza, Ph.D.      22,420,192   619,342       7,253,724
Marsha Fanucci             22,728,776   310,758       7,253,724
Peter M. Hecht, Ph.D.      22,861,987   177,547       7,253,724
Ole Isacson, M.D., Ph.D.   22,965,559    73,975       7,253,724
Stephanie Lovell           22,971,405    68,129       7,253,724
Terrance McGuire           22,738,211   301,323       7,253,724
Michael Mendelsohn, M.D.   22,620,671   418,863       7,253,724

2. Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2022:



   For       Against   Abstain
30,226,143   53,476    13,639



                                       2

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses